Mesenchymal stem cells (MSCs) have the ability to migrate to the site of injury or inflammation, and to contribute to the healing process. Since patients treated with MSCs are often users of analgesic drugs, to relieve their uncomfortable pain associated with the tissue disorder, there is a possibility of negative effects of these drugs on the migration of endogenous and exogenous MSCs. Therefore, we tested the impact of acute and chronic treatment with morphine on the migration and organ distribution of exogenous adipose tissue-derived MSCs in mouse models. Firstly, we showed that the incubation of MSCs with morphine significantly reduced the expression of adhesive molecules CD44 (HCAM), CD54 (ICAM-1) and CD106 (VCAM-1) on MSCs. Using a model of systemic administration of MSCs labeled with vital dye PKH26 and by the application of flow cytometry to detect living CD45-PKH26+ cells, we found a decreased number of labeled MSCs in the lung, spleen and bone marrow, and a significantly increased number of MSCs in the liver of morphine-treated recipients. A skin allograft model was used to study the effects of morphine on the migration of exogenous MSCs to the superficial wound. Intraperitoneally administered MSCs migrated preferentially to the wound site, and this migration was significantly decreased in the morphine-treated recipients. The present results showed that morphine significantly influences the distribution of exogenous MSCs in the body, and decreases their migration to the site of injury.

Department of Biomathematics Institute of Physiology of the Czech Academy of Sciences 142 20 Prague 4 Czech Republic

Department of Cell Biology Faculty of Science Charles University 128 43 Prague 2 Czech Republic

Department of Nanotoxicology and Molecular Epidemiology Institute of Experimental Medicine of the Czech Academy of Sciences 142 20 Prague 4 Czech Republic

Zobrazit více v PubMed

Sasaki, M., Abe, R., Fujita, Y., Ando, S., Inokuma, D., & Shimizu, H. (2008). Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. Journal of Immunology, 180, 2581–2587. DOI

Lan, Y., Kodati, S., Lee, H. S., Omoto, M., Jin, Y., & Chauhan, S. K. (2012). Kinetics and function of mesenchymal stem cells in corneal injury. Investigative Ophthalmology and Visual Sciences, 53, 3638–3644. DOI

Javorkova, E., Trosan, P., Zajicova, A., Krulova, M., Hajkova, M., & Holan, V. (2014). Modulation of the early inflammatory microenvironment in the alkali-burned eye by systemically administered interferon-γ-treated mesenchymal stromal cells. Stem Cells and Development, 23, 2490–2500. DOI

Assis, A. C., Carvalho, J. L., Jacoby, B. A., Ferreira, R. L., Castanheira, P., Diniz, S. O., Cardoso, V. N., Goes, A. M., & Ferreira, A. J. (2010). Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart. Cell Transplantation, 19, 219–230. DOI

Wu, Y., & Zhao, R. C. (2012). The role of chemokines in mesenchymal stem cell homing to myocardium. Stem Cell Reviews and Reports, 8, 243–250. DOI

Singh, A., Singh, A., & Sen, D. (2016). Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010–2015). Stem Cell Research and Therapy, 7(1), 82. https://doi.org/10.1186/s13287-016-0341-0 . PubMed DOI PMC

Cardenes, N., Aranda-Valderrama, P., Carney, J. P., Sellares Torres, J., Alvarez, D., Kocydirim, E., Wolfram Smith, J. A., Ting, A. E., Lagazzi, L., Yu, Z., Mason, S., Santos, E., Lopresti, B. J., & Rojas, M. (2019). Cell therapy for ARDS: efficacy of endobronchial versus intravenous administration and biodistribution of MAPCs in a large animal model. BMJ Open Respiratory Research. https://doi.org/10.1136/bmjresp-2018-000308 . PubMed DOI PMC

Hajkova, M., Jaburek, F., Porubska, B., Bohacova, P., Holan, V., & Krulova, M. (2019). Cyclosporine A promotes the therapeutic effect of mesenchymal stem cells on transplantation reaction. Clinical Science (London), 133, 2143–2157. DOI

Eggenhofer, E., Benseler, V., Kroemer, A., Popp, F. C., Geissler, E. K., Schlitt, H. J., Baan, C. C., Dahlke, M. H., & Hoogduijn, M. J. (2012). Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. Frontiers in Immunology, 3, 297. DOI

Leibacher, J., & Henschler, R. (2016). Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells. Stem Cell Research and Therapy, 7, 7. https://doi.org/10.1186/s13287-015-0271-2 .

Ji, J. F., He, B. P., Dheen, S. T., & Tay, S. S. (2004). Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells, 22, 415–427. DOI

Chamberlain, G., Wright, K., Rot, A., Ashton, B., & Middleton, J. (2008). Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: comparison with human. PLoS One, 3(8), e2934. https://doi.org/10.1371/journal.pone.0002934 . PubMed DOI PMC

Rankin, S. M. (2012). Chemokines and adult bone marrow stem cells. Immunology Letters, 145, 47–54. DOI

Nitzsche, F., Müller, C., Lukomska, B., Jolkkonen, J., Deten, A., & Boltze, J. (2017). Concise Review: MSC adhesion cascade-insights into homing and transendothelial migration. Stem Cells, 35, 1446–1460. DOI

Abumaree, M., Al Jumah, M., Pace, R. A., & Kalionis, B. (2012). Immunosuppressive properties of mesenchymal stem cells. Stem Cell Reviews, 8, 375–392. DOI

English, K. (2013). Mechanisms of mesenchymal stromal cell immunomodulation. Immunology and Cell Biology, 91, 19–26. DOI

Holan, V., Hermankova, B., Bohacova, P., Kossl, J., Chudickova, M., Hajkova, M., Krulova, M., Zajicova, A., & Javorkova, E. (2016). Distinct immunoregulatory mechanisms in mesenchymal stem cells: Role of the cytokine environment. Stem Cell Reviews, 12, 654–663. DOI

Bayer, R., Franke., H., Ficker, C., Richter, M., Lessig, R., Büttner, A., & Weber, M. (2015). Alterations of neuronal precursor cells in stages of human adult neurogenesis in heroin addicts. Drug and Alcohol Dependence, 156, 139–149. DOI

Barlass, U., Dutta, R., Cheema, H., George, J., Sareen, A., Dixit, A., Yuan, Z., Giri, B., Meng, J., Banerjee, S., Banerjee, S., Dudeja, V., Dawra, R. K., Roy, S., & Saluja, A. K. (2017). Morphine worsens the severity and prevents pancreatic regeneration in mouse models of acute pancreatitis. Gut. https://doi.org/10.1136/gutjnl-2017-313717 . PubMed DOI

Wang, Y., Gupta, M., Farooqui, M., Li, Y., Peng, F., Rao, S., Ansonoff, M., Pintar, J. E., & Gupta, K. (2017). Opioids and opioid receptors orchestrate wound repair. Translational Research, 185, 13–23. DOI

Holan, V., Cechova, K., Zajicova, A., Kossl, J., Hermankova, B., Bohacova, P., Hajkova, M., Krulova, M., Svoboda, P., & Javorkova, E. (2018). The impact of morphine on the characteristics and function properties of human mesenchymal stem cells. Stem Cell Reviews and Reports, 14, 801–811. DOI

Hajkova, M., Javorkova, E., Zajicova, A., Trosan, P., Holan, V., & Krulova, M. (2017). A local application of mesenchymal stem cells and cyclosporine A attenuates immune response by a switch in macrophage phenotype. Journal of Tissue Engineering and Regenerative. Medicine, 11, 1456–1465. DOI

Billingham, R. E., Brent, L., Medawar, P. B., & Sparrow, E. M. (1954). Quantitative studies on tissue transplantation immunity. I. The survival times of skin homografts exchanged between members of different inbred strains of mice. Proceedings of the Royal Society of London B: Biological Sciences, 143, 43–58. PubMed

Rook, J. M., & McCarson, K. E. (2007). Delay of cutaneous wound closure by morphine via local blockade of peripheral tachykinin release. Biochemical Pharmacology, 74, 752–757. DOI

Bortolotto, V., & Grilli, M. (2017). Opiate analgesics as negative modulators of adult hippocampal neurogenesis: Potential implications in clinical practice. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2017.00254 . PubMed DOI PMC

Lam, C. F., Chang, P. J., Huang, Y. S., et al. (2008). Prolonged use of high-dose morphine impairs angiogenesis and mobilization of endothelial progenitor cells in mice. Anesthesia and Analgesia, 107, 686–692. DOI

Zhang, J., Huang, X., Wang, H., Liu, X., Zhang, T., Wang, Y., & Hu, D. (2015). The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy. Stem Cell Research and Therapy, 6, 234. DOI

Shim, G., Lee, S., Han, J., Kim, G., Jin, H., Miao, W., Yi, T. G., Cho, Y. K., Song, S. U., & Oh, Y. K. (2015). Pharmacokinetics and in vivo fate of intra-articularly transplanted human bone marrow-derived clonal mesenchymal stem cells. Stem Cells and Development, 24, 1124–1132. DOI

Herrera, M. B., Bussolati, B., Bruno, S., Morando, L., Mauriello-Romanazzi, G., Sanavio, F., Stamenkovic, I., Biancone, L., & Camussi, G. (2007). Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney International, 72, 430–441. DOI

Wagner, W., Ho, A. D., & Zenke, M. (2010). Different facets of aging in human mesenchymal stem cells. Tissue Engineering Part B Reviews, 16, 445–453. DOI

Rombouts, W. J., & Ploemacher, R. E. (2003). Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia, 17, 160–170. DOI

Liu, X. B., Chen, H., Chen, H. Q., Zhu, M. F., Hu, X. Y., Wang, Y. P., Jiang, Z., Xu, Y. C., Xiang, M. X., & Wang, J. A. (2012). Angiopoietin-1 preconditioning enhances survival and functional recovery of mesenchymal stem cell transplantation. Journal of Zhejiang University - Science B, 13, 616–623. DOI

Rook, J. M., Hasan, W., & McCarson, K. E. (2009). Morphine-induced early delays in wound closure: involvement of sensory neuropeptides and modification of neurokinin receptor expression. Biochemical Pharmacology, 77, 1747–1755. DOI

Chrastil, J., Sampson, C., Jones, K. B., & Higgins, T. F. (2013). Postoperative opioid administration inhibits bone healing in an animal model. Clinical Orthopaedics and Related Research, 471, 4076–4081. DOI

Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials

Expression of Opioid Receptors in Cells of the Immune System